Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2007
03/07/2007EP1542680B1 1, 4, 5-substituted 1, 2-dihydro-pyrazol-3-one and 3-alkoxy-1h-pyrazole derivatives as tnf-alpha and interleukin lowering agents for the treatment of inflammations
03/07/2007EP1442025B1 Pyrimidinones as melanin concentrating hormone receptor 1
03/07/2007EP1440066B1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
03/07/2007EP1381370B1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
03/07/2007EP1372651B1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
03/07/2007EP1187811B1 Inhibitors of metalloproteinases
03/07/2007EP0959076B1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics
03/07/2007CN1926141A Metal complexes of N-heterocyclic carbenes as radiopharmaceuticals and antibiotics
03/07/2007CN1926137A Pyrrole-derivatives as factor Xa inhibitors
03/07/2007CN1926136A Amino cyclopropane carboxamide derivatives as bradykinin antagonists
03/07/2007CN1926135A Cycloalkyl derivatives of 3-hydroxy-4-pyridinones
03/07/2007CN1926134A 2-pyridinylethylcarboxamide derivatives and their use as fungicides
03/07/2007CN1926132A Pyrazole compounds useful as protein kinase inhibitors
03/07/2007CN1926129A Novel insecticides
03/07/2007CN1926128A Dipeptidyl peptidase inhibitors
03/07/2007CN1926127A Novel 2-heteroaryl-substituted benzimidazole derivative
03/07/2007CN1926117A 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power
03/07/2007CN1926113A Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
03/07/2007CN1926111A Novel isoamido-substituted hydroxy-6-phenylphenanthridines
03/07/2007CN1926110A Novel heterocyclyl-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
03/07/2007CN1926109A Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
03/07/2007CN1926106A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
03/07/2007CN1926105A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
03/07/2007CN1926103A Sulphonylpyrroles as HDAC inhibitors
03/07/2007CN1925859A 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as GABA receptor ligands for the treatment of anxiety, depression and epilepsy
03/07/2007CN1923832A Novel pyridazinone compound, preparation method and application thereof
03/07/2007CN1923812A New compounds
03/07/2007CN1923797A Pharmaceutical compounds
03/07/2007CN1303161C Novel anthrapyridone compounds, water-base magenta ink compositions, and ink-jet recording process
03/07/2007CN1303080C Nolatrexed hydrochloride synthesis process
03/07/2007CN1303071C Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof
03/07/2007CN1303067C Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
03/07/2007CN1303066C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
03/06/2007US7186870 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function
03/06/2007US7186843 Aminomethylpyrrolidine derivatives having aromatic substituents
03/06/2007US7186841 Antiinflammation agents
03/06/2007US7186838 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
03/06/2007US7186836 Thienyl compounds
03/06/2007US7186834 Substituted iminoazines
03/06/2007US7186833 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders
03/06/2007US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents
03/06/2007US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
03/06/2007US7186746 Indoles having anti-diabetic activity
03/06/2007US7186743 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics
03/06/2007US7186741 Neurotensin active 2,3,diaryl-pyrazolidine derivatives
03/06/2007US7186739 O-succinimidyl-2-[(9H-fluoren-9-ylmethoxy)carbonylamino]-ethylcarbamate's used as monomers active in the synthesis of di- and tri-substituted ureas and urea oligomers
03/06/2007US7186737 Inhibitors of p38
03/06/2007US7186735 Vasodilation; cardiovascular disorders; anticoagulants
03/06/2007US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders
03/06/2007US7186733 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
03/06/2007US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders
03/06/2007US7186731 2-cyanopyrrolidinecarboxamide compound
03/06/2007US7186727 Pyridyl-substituted spiro-hydantoin compounds and use thereof
03/06/2007US7186726 Preferentially substituted calcium channel blockers
03/06/2007US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
03/06/2007US7186723 Tyrosine kinase inhibitors
03/06/2007US7186722 active against sensitive and resistant species and against all development stages
03/06/2007US7186720 Moderator of tumor necrosis factor; antiinflammatory agents; autoimmune diseases
03/06/2007US7186719 Antibacterial agents
03/06/2007US7186716 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
03/06/2007US7186715 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
03/06/2007US7186714 administering drugs such as 3-[2-(Cyclopentylamino)-4-pyrimidinyl]-2-(4-fluorophenyl)imidazo[1,2-a]pyridin-8-amine, for therapy of viral diseases caused by DNA viruses
03/06/2007US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders
03/06/2007CA2312493C Novel suppository form comprising an acid-labile active compound
03/06/2007CA2200898C Process for the preparation of arylamides of heteroaromatic carboxylic acids
03/01/2007WO2007024944A1 Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists
03/01/2007WO2007024922A1 Immunosuppressant compounds and compositions
03/01/2007WO2007024833A1 Anthranilamides for controlling invertebrate pests
03/01/2007WO2007024680A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators
03/01/2007WO2007024004A1 Phenylpyridone derivative
03/01/2007WO2007023882A1 Derivative having ppar agonistic activity
03/01/2007WO2007023840A1 1,3,5-triazine derivative, method for producing same, and organic electroluminescent device containing same as component
03/01/2007WO2007023775A1 Therapeutic agent for atrial fibrillation
03/01/2007WO2007023768A1 Novel pyridine derivative and pyrimidine derivative (3)
03/01/2007WO2007023382A2 Pyrimidine amino pyrazole compounds, potent kinase inhibitors
03/01/2007WO2007023186A1 Pyrazine derivatives and use as pi3k inhibitors
03/01/2007WO2007023182A1 Delta and epsilon crystal forms of imatinib mesylate
03/01/2007WO2007023073A2 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof
03/01/2007WO2007022946A1 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors
03/01/2007WO2007022938A2 Compounds
03/01/2007WO2007022937A1 Pyridazine derivatives with antiinflammatory activity
03/01/2007WO2007022845A1 Novel materials for organic electroluminescent devices
03/01/2007WO2007022638A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
03/01/2007WO2007002637B1 N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/01/2007WO2007002181A3 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm)
03/01/2007WO2006124748A3 Multicyclic compounds and methods of their use
03/01/2007WO2006116157A9 Dipeptidyl peptidase-iv inhibitors
03/01/2007WO2006098969A3 Quinazolinone t-type calcium channel antagonists
03/01/2007WO2006081273A8 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity
03/01/2007WO2006036994A3 Modulators of crth2, cox-2 and faah
03/01/2007WO2005117882A9 Hydroxamic acid derivatives as metalloprotease inhibitors
03/01/2007WO2005117876A8 Dual small molecule inhibitors of cancer and angiogenesis
03/01/2007US20070049623 1-(Hetero)aryl- and 3-substituted with a group containing an arylaldehyde oxime, e.g., 4-[5-(2-oxo-3-pyridin-4-yl-imidazolidin-1-yl)-pentyloxy]-benzaldehyde O-methyl-oxime; treating enteroviral infections
03/01/2007US20070049620 Cyclic tertiary amine compound
03/01/2007US20070049611 Phosphodiesterase 4 inhibitors
03/01/2007US20070049595 Autoimmune disease; antiinflammatory agents; antiischemic agents; rheumatic diseases; antiarthritic agents; osteoporosis
03/01/2007US20070049592 Bis-aryl urea compounds and methods of use
03/01/2007US20070049584 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine
03/01/2007US20070049582 Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression
03/01/2007US20070049580 Anxiolytic agents with reduced sedative and ataxic effects